Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

Linked2Safety · A NEXT-GENERATION, SECURE LINKED DATA MEDICAL INFORMATION SPACE FOR SEMANTICALLY-INTERCONNECTING ELECTRONIC HEALTH RECORDS AND CLINICAL TRIALS SYSTEMS ADVANCING PATIENTS SAFETY IN CLINICAL RESEARCH

FP7Status: CLOSED1 October 201130 September 2014EU funding €3,099,000

The vision of the proposed Linked2Safety project is to advance clinical practice and accelerate medical research, to improve the quality of healthcare, benefiting public health, and to enhance patients' safety; by providing pharmaceutical companies, healthcare professionals and patients with an innovative semantic interoperability framework, a sustainable business model, and a scalable technical infrastructure & platform for the efficient, homogenized access to and the effective, viable utilization of the increasing wealth of medical information contained in the EHRs deployed and maintained at regional and/or national level across Europe, dynamically interconnecting distributed patients data to medical research efforts, respecting patients' anonymity, as well as European and national legislation.The 36-month Linked2Safety project with the developed reference architecture, data protection framework, common EHR schema, lightweight semantic model and integrated platform will facilitate the scalable and standardized semantic interlinking, sharing and reuse of heterogeneous EHR repositories, which will provide healthcare professionals, clinical researchers and pharmaceutical companies experts with a user-friendly, sophisticated, collaborative decision-making environment for:a.\tanalyzing all the available data including the genetic, environmental and medical history of subjects that exhibit adverse events occurring in the frame of clinical trials, based on the clinical care information existing in the specific patients' EHR, leading to the identification of the phenotype and genotype factors that are associated with specific adverse events and thus having direct impact on the patient safety through the early detection of potential patient safety issues.b.\twide identification and selection of patients for clinical trials, though the seamless and standardized linking with heterogeneous EHR repositories, providing advice on the best design of clinical studies

Consortium · 13 organisations

coordinator

NETCOMPANY-INTRASOFT SA

LU · €399,778

participant

UNIVERSITY OF GALWAY

IE · €356,000

participant

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS

EL · €298,250

participant

THE UNIVERSITY OF MANCHESTER

UK · €293,694

participant

GIOUMPITEK MELETI SCHEDIASMOS YLOPOIISI KAI POLISI ERGON PLIROFORIKIS ETAIREIA PERIORISMENIS EFTHYNIS

EL · €292,800

participant

ZEINCRO HELLAS ANONYMI ETAIREIA KATA ANATHESI PAROCHIS YPIRESION STOUS TOMEIS YGEIAS

EL · €185,360

participant

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS

CH · €169,200

participant

KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA

CY · €165,300

participant

EUROSOFT DEVELOPMENT SA

RO · €250,915

participant

UNIVERSITY OF CYPRUS

CY · €424,600

participant

COMPUGROUP MEDICAL AG

DE

participant

GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER

DE · €263,103

participant

NeuroSearch A/S

DK

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.